Home/Filings/4/0001209191-16-118824
4//SEC Filing

Horizon Pharma plc 4

Accession 0001209191-16-118824

CIK 0001492426operating

Filed

May 9, 8:00 PM ET

Accepted

May 10, 4:42 PM ET

Size

8.9 KB

Accession

0001209191-16-118824

Insider Transaction Report

Form 4
Period: 2016-05-06
Pauli Ronald
Director
Transactions
  • Tax Payment

    Ordinary Shares

    2016-05-06$13.41/sh1,418$19,0153,840 total(indirect: By Trust)
  • Exercise/Conversion

    Restricted Stock Units

    2016-05-065,2580 total
    Ordinary Shares (5,258 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2016-05-06+5,2585,258 total(indirect: By Trust)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]On May 6, 2015, the reporting person was granted 5,258 restricted stock units, vesting in full on the first anniversary of the grant date.

Issuer

Horizon Pharma plc

CIK 0001492426

Entity typeoperating
IncorporatedIreland

Related Parties

1
  • filerCIK 0001492426

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:42 PM ET
Size
8.9 KB